When was Matterworks founded?

Matterworks was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Matterworks located?

Matterworks is headquartered in Somerville, United States.

How many employees does Matterworks have?

As of Jun 30, 2026, the latest employee count at Matterworks is 48.

Is Matterworks a funded company?

Matterworks is a funded company, having raised a total of $15.9M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 04, 2020.

When was the latest funding round of Matterworks?

Matterworks' latest funding was a $***** Series A round on Jun 03, 2025, with participation from 6 investors.

Where does Matterworks rank among its competitors?

Matterworks ranks 4th amongst 26 active competitors, of which 6 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Moleculent, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Matterworks?

Matterworks' top competitors include Enterome, Moleculent and Leman Biotech. Among them, Moleculent secured the most recent funding round in May, 2026.

Matterworks - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI and analytical platform to accelerate therapeutic research. The company has developed the Large Spectral Model and Pyxis, a product that enables scalable quantitative metabolomics with AI. It has ability to identify and quantify features from raw untargeted data, providing quantitative results automatically.

Website: www.matterworks.ai/
Social

Key Metrics

Founded Year

2019

Location

Somerville, United States

Stage

Series A

Total Funding

$15.9M in 4 rounds

Latest Funding Round

Series A, Jun 03, 2025, $*****

Investors

Lewis & Clark Partners & 8 more

Ranked

4^th among 26 active competitors

Employee Count

48 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2372 more

View Matterworks' full profile

Matterworks is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MATTERWORKS, INC. CIN: 842436414 , United States, Active	Dec 31, 1999	-	22 (As on Dec 31, 2024)	-

Matterworks has raised a total funding of $15.9M over 4 rounds. Its first funding round was on Aug 04, 2020. Its latest funding round was a Series A round on Jun 03, 2025 for $*****. 6 investors participated in its latest round. Matterworks has 9 institutional investors.

Here is the list of recent funding rounds of Matterworks:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2025	3856955	Series A	2996176	2942713	9092167	5527135
Mar 15, 2022	2027160	Series A	7705469	8950751	3232872	Jungle Ventures
Nov 12, 2020	8329019	Series A	4208426	4833483	2754151	Bling Capital

Access funding benchmarks and valuations. Sign up today!

View details of Matterworks's funding rounds and investors

The founders of Matterworks is Mimoun Cadosch Delmar.

Here are the details of Matterworks' key team members:

Mimoun Cadosch Delmar: Former Co-Founder of Matterworks.

View details of Matterworks's Founder profiles and Board Members

Matterworks' employee count trend

Matterworks has 48 employees as of Jun 26. Here is Matterworks's employee count trend over the years:

Uncover Matterworks' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Matterworks include Enterome, Moleculent and Leman Biotech. Here is the list of Top 10 competitors of Matterworks, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Enterome 2008, Paris (France), Series E	Developer of immunomodulatory drugs targeting cancer and immune diseases	$130M	Seventure Partners, Lundbeck Foundation & 10 others	57/100
2nd	Moleculent 2019, Solna (Sweden), Series A	Provider of a biology platform that detects cell-cell interactions within their tissue environment	$46M	Eir Ventures, Arch Venture Partners & 1 others	55/100
3rd	Leman Biotech 2021, Shenzhen (China), Series A	Develope rof AI-based platform for cancer immunotherapy	$42.9M	FUHO Capital Management, Jingtai Technology ... & 7 others	50/100
4th	Matterworks 2019, Somerville (United States), Series A	AI and analytical platform to accelerate therapeutic research	$15.9M	Jungle Ventures, Bling Capital & 7 others	48/100
5th	Vizzhy 2019, Austin (United States), Seed	Provider of multi omics based metabolic signature program and solutions for metabolic health issues	-	Genie Healthcare	47/100
6th	Oria Bioscience 2024, Paris (France), Unfunded	Provider of AI tools and drug screening based on human cells and organoids	-	-	34/100
7th	Clarity Bio Systems 2020, Mumbai (India), Funding Raised	Developer of metabolomics analysis software and provider of analytical services	-	SINE	33/100
8th	Miphic 2022, Bergen (Norway), Seed	Provider of mitochondrial screening platform for diagnostics	$20K	Techstars, Creator Fund	28/100
9th	metwarebio.com 2015, Woburn (United States), Funding Raised	Provider of metabolomics, proteomics, lipidomics, and multi-omics research services	-	Europa	27/100
10th	Tranquil Immune 2021, Bonn (Germany), Unfunded	Developer of technology for developing auto-immune disease therapeutics	-	-	24/100